Wells Fargo & Company Adaptimmune Therapeutics PLC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Wells Fargo & Company holds 66,821 shares of ADAP stock, worth $36,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,821
Previous 63,672 4.95%
Holding current value
$36,083
Previous $62,000 1.61%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.92 - $1.39 $2,897 - $4,377
3,149 Added 4.95%
66,821 $63,000
Q2 2024

Aug 13, 2024
BUY
$0.83 - $1.47 $7,885 - $13,965
9,500 Added 17.54%
63,672 $62,000
Q1 2024

May 10, 2024
SELL
$0.7 - $1.75 $1,403 - $3,508
-2,005 Reduced 3.57%
54,172 $85,000
Q4 2023

Feb 09, 2024
BUY
$0.43 - $0.79 $615 - $1,131
1,432 Added 2.62%
56,177 $44,000
Q3 2023

Nov 13, 2023
SELL
$0.73 - $1.04 $4,009 - $5,711
-5,492 Reduced 9.12%
54,745 $42,000
Q2 2023

Aug 15, 2023
BUY
$0.9 - $1.51 $48,633 - $81,595
54,037 Added 871.56%
60,237 $55,000
Q2 2022

Aug 12, 2022
SELL
$1.33 - $2.28 $2,122 - $3,638
-1,596 Reduced 20.47%
6,200 $10,000
Q1 2022

May 16, 2022
BUY
$1.73 - $4.06 $4,229 - $9,926
2,445 Added 45.69%
7,796 $15,000
Q3 2021

Nov 15, 2021
SELL
$3.44 - $6.37 $35,497 - $65,732
-10,319 Reduced 65.85%
5,351 $27,000
Q2 2021

Aug 16, 2021
BUY
$3.86 - $5.78 $15,436 - $23,114
3,999 Added 34.26%
15,670 $67,000
Q1 2021

May 13, 2021
BUY
$4.9 - $6.83 $22,099 - $30,803
4,510 Added 62.98%
11,671 $61,000
Q4 2020

Feb 09, 2021
BUY
$4.0 - $9.2 $16,640 - $38,272
4,160 Added 138.62%
7,161 $39,000
Q3 2020

Nov 05, 2020
BUY
$7.66 - $10.78 $8,081 - $11,372
1,055 Added 54.21%
3,001 $25,000
Q2 2020

Aug 13, 2020
BUY
$2.58 - $12.1 $4,375 - $20,521
1,696 Added 678.4%
1,946 $20,000
Q1 2020

May 14, 2020
BUY
$1.2 - $4.52 $300 - $1,130
250 New
250 $1,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $88.2M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email